Zobrazeno 1 - 10
of 38
pro vyhledávání: '"I S Preobrazhenskaya"'
Autor:
N N Yakhno, I S Preobrazhenskaya, V V Zakharov, D A Stepkina, A B Lokshina, E A Mkhitaryan, N N Koberskaya, I Yu Savushkina
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 4, Iss 2, Pp 30-35 (2012)
The paper gives the data obtained from the preliminary analysis of the activities of RussiaХs first Memory Impairment Laboratory. The findings allowed the authors to estimate the approximate prevalence of cognitive impairments (CIs) in patients with
Externí odkaz:
https://doaj.org/article/f1ab6f6e736942b481b553515268905e
Autor:
I. G. Tishkova, I. S. Preobrazhenskaya
Publikováno v:
Анналы клинической и экспериментальной неврологии, Vol 4, Iss 2, Pp 15-22 (2017)
In dementia with Lewy bodies (DLB) neurodegenerative processaffects not only central, but also peripheral nervous structures,most frequently, neurons of autonomic ganglia, which mayunderlay autonomic dysfunction, including peripheral autonomicfailure
Externí odkaz:
https://doaj.org/article/37453c161254485b888fcd9da102c69c
Publikováno v:
Meditsinskiy sovet = Medical Council. :24-32
Introduction. The COVD-19 pandemic caused by the SARS-CoV-2 continues from March 2020. The virus primarily affects the respiratory system. Moreover, there is new data about the various organ damage caused by COVID-19 such as heart, skin, kidney and c
Autor:
I. S. Preobrazhenskaya
Publikováno v:
Behavioral Neurology. :56-63
Autor:
O. N. Voskresenskaya, Dmitry Napalkov, P. M. Krupenin, V. A. Perepelov, I. S. Preobrazhenskaya, E. V. Sidorov, E. M. Perepelova, S. P. Bordovsky, A. A. Sokolova
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 20, Iss 4 (2021)
Aim. To test a hypothesis of hypoperfusion-induced white matter changes in patients with atrial fibrillation (AFib) and to present statistics to compute sample size for the upcoming studies.Material and methods. We included 30 inpatients with AFib an
Autor:
I. S. Preobrazhenskaya
Publikováno v:
Медицинский совет, Vol 0, Iss 10, Pp 26-31 (2017)
The article presents modern data on the causes of development, diagnostic methods and treatment approaches of Alzheimer’s disease. Special attention is given to pathogenetic and symptomatic therapy of this disease, as well as non-drug treatments.
Autor:
Dmitry Napalkov, P. M. Krupenin, Yana Kirichuk, A. A. Sokolova, Mariia Gabitova, I. S. Preobrazhenskaya, Sergey Bordovsky
Publikováno v:
Journal of the neurological sciences. 394
Mild cognitive impairment (MCI) in patients with cardiovascular risks is a transitional state to vascular dementia but which still has a possibility of being managed. The objectives of this study were to assess the impact of atrial fibrillation (AF)
Publikováno v:
Nevrologiâ, Nejropsihiatriâ, Psihosomatika, Vol 8, Iss 4, Pp 91-97 (2016)
Early diagnosis of Alzheimer's disease (AD) is one of the most important tasks of modern medicine. Even before its obvious clinical symptoms develop, AD can be now identified from the data of functional neuroimaging, including that with the Pittsburg
Autor:
A. A. Naumenko, I. S. Preobrazhenskaya
Publikováno v:
Медицинский совет, Vol 0, Iss 5, Pp 46-54 (2015)
The article is devoted to pathogenesis and diagnosis of Alzheimer's disease. The possibilities of treatment are discussed. Efficacy data for the basic symptomatic treatment of Alzheimer's disease, the potential and prospects of nootropic therapy are
Autor:
I. S. Preobrazhenskaya, D. O. Gromova
Publikováno v:
Медицинский совет, Vol 0, Iss 10, Pp 26-30 (2014)
The article tells about current approaches to diagnosis and treatment of vascular cognitive impairment. The focus is on the administration of neurometabolic medicines.